CDER's Generational Shift: Many New Reviewers With Little Experience
Executive Summary
The last two fiscal years have seen great gains in the number of new employees hired in FDA's Center for Drug Evaluation & Research, but the result is a relatively under-experienced staff: 38 percent of employees in both CDER and the Office of New Drugs have less than two years of on-the-job experience
You may also be interested in...
200 CDER Staff Say Goodbye To White Oak, For Now
Approximately 200 employees in FDA’s Center for Drug Evaluation and Research are being exiled from the agency’s White Oak campus for the next few years, due to overcrowding.
200 CDER Staff Say Goodbye To White Oak, For Now
Approximately 200 employees in FDA’s Center for Drug Evaluation and Research are being exiled from the agency’s White Oak campus for the next few years, due to overcrowding.
The State of New Drug Reviews in the US
Drug approvals are up. FDA is back to on-time reviews for most new drug applications. The user fee era survived its toughest test. But industry still needs to adjust to a changed environment forthe new realities of new drug reviews in the US.